羚锐制药 - Financials

羚锐制药 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	3.5B	3.3B	3.0B	2.7B	2.3B
Revenue Growth %	5.7%	10.3%	11.4%	15.5%	--
Total Revenue	3.5B	3.3B	3.0B	2.7B	2.3B
Cost Of Revenue	847.0M	884.0M	832.0M	693.0M	538.0M
+Gross Profit	2.7B	2.4B	2.2B	2.0B	1.8B
Gross Margin %	75.8%	73.3%	72.3%	74.3%	76.9%
Total Operating Cost	2.8B	2.7B	2.6B	2.3B	2.0B
Selling Expenses	1.6B	1.5B	1.4B	1.3B	1.2B
Admin Expenses	167.0M	174.0M	169.0M	189.0M	166.0M
Rd Expenses	132.0M	110.0M	125.0M	86.2M	97.8M
Finance Expenses	-18.9M	-35.1M	-26.6M	-10.3M	-15.3M
+Operating Income	810.0M	656.0M	517.0M	435.0M	367.0M
Operating Margin %	23.1%	19.8%	17.2%	16.1%	15.7%
Non Operating Income	22.9M	434,400	809,800	2.1M	3.9M
Non Operating Expenses	5.6M	3.7M	896,800	23.8M	6.8M
Investment Income	40.2M	20.2M	58.7M	30.6M	41.2M
Fair Value Change Income	-10,500	120,700	5.9M	45,900	-52,100
Asset Disposal Income	12,100	47,700	24,600	34,600	79,500
Asset Impairment Loss	501,800	2.9M	170,500	8.8M	32.0M
Other Income	43.6M	16.6M	38.8M	17.5M	16.2M
Income Before Tax	828.0M	653.0M	517.0M	413.0M	364.0M
Income Tax	105.0M	84.9M	51.7M	50.9M	39.8M
+Net Income	723.0M	568.0M	465.0M	362.0M	324.0M
Net Margin %	20.7%	17.2%	15.5%	13.4%	13.9%
Net Income Attributable	723.0M	568.0M	465.0M	362.0M	325.0M
Minority Interest	34,000	6,400	400.00	957,000	-1.1M
Eps Basic	1.29	1.01	0.84	0.65	0.57
Eps Diluted	1.28	1.00	0.82	0.64	0.57

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	1.2B	1.5B	1.2B	801.0M	732.0M
Trading Financial Assets	--	206,100	150.0M	280.0M	57.2M
Accounts Receivable	319.0M	258.0M	196.0M	173.0M	146.0M
Notes Receivable	152.0M	213.0M	251.0M	228.0M	495.0M
Notes And Accounts Receivable	472.0M	472.0M	447.0M	401.0M	641.0M
Prepayments	12.5M	14.7M	27.1M	24.6M	26.7M
Inventory	435.0M	467.0M	486.0M	428.0M	331.0M
Total Current Assets	2.5B	2.6B	2.5B	2.1B	1.9B
Long Term Equity Investment	73.1M	71.3M	71.7M	117.0M	98.6M
Fixed Assets	--	636.0M	697.0M	698.0M	727.0M
Fixed Assets Total	588.0M	636.0M	697.0M	698.0M	727.0M
Construction In Progress	--	2.9M	1.9M	24.8M	2.8M
Construction In Progress Total	34.2M	2.9M	1.9M	24.8M	2.8M
Intangible Assets	204.0M	203.0M	204.0M	237.0M	235.0M
Long Term Deferred Expenses	6.9M	9.4M	13.3M	16.1M	39.3M
Total Non Current Assets	2.6B	2.2B	1.8B	1.7B	1.5B
Total Assets	5.0B	4.8B	4.3B	3.8B	3.5B
Short Term Borrowings	33.3M	141.0M	93.8M	126.0M	20.0M
Accounts Payable	85.1M	57.4M	68.0M	78.0M	78.8M
Advance Receipts	63,200	99,700	63,900	63,100	20,200
Contract Liabilities	114.0M	114.0M	154.0M	79.1M	71.7M
Total Current Liabilities	1.9B	1.9B	1.7B	1.4B	1.1B
Long Term Borrowings	--	--	--	--	--
Total Non Current Liabilities	62.2M	73.1M	74.3M	68.9M	69.3M
Total Liabilities	1.9B	2.0B	1.8B	1.5B	1.1B
Paid In Capital	567.0M	567.0M	567.0M	568.0M	568.0M
Capital Reserve	341.0M	326.0M	310.0M	272.0M	320.0M
Surplus Reserve	285.0M	284.0M	284.0M	263.0M	215.0M
Retained Earnings	1.9B	1.6B	1.4B	1.2B	1.1B
Minority Equity	7.8M	7.7M	7.5M	7.6M	9.4M
Equity Attributable	3.1B	2.8B	2.6B	2.3B	2.3B
Total Equity	3.1B	2.8B	2.6B	2.3B	2.3B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	3.8B	3.7B	3.2B	3.2B	2.6B
Tax Refunds Received	761,800	758,100	1.5M	706,600	3.6M
Total Operating Cash Inflow	3.9B	3.7B	3.4B	3.3B	2.6B
Cash Paid For Goods	715.0M	802.0M	673.0M	722.0M	541.0M
Cash Paid To Employees	368.0M	385.0M	326.0M	248.0M	230.0M
Taxes Paid	494.0M	477.0M	397.0M	357.0M	318.0M
Total Operating Cash Outflow	3.0B	2.9B	2.5B	2.4B	2.2B
Operating Cash Flow	876.0M	813.0M	835.0M	846.0M	451.0M
Total Investing Cash Inflow	466.0M	524.0M	1.1B	2.1B	1.6B
Total Investing Cash Outflow	1.1B	754.0M	1.2B	2.7B	1.6B
Investing Cash Flow	-666.0M	-230.0M	-83.8M	-546.0M	11.9M
Cash From Borrowings	40.4M	103.0M	90.0M	236.0M	172.0M
Dividends And Interest Paid	451.0M	344.0M	289.0M	224.0M	179.0M
Debt Repayments	103.0M	20.0M	170.0M	130.0M	287.0M
Total Financing Cash Inflow	84.2M	103.0M	90.0M	312.0M	172.0M
Total Financing Cash Outflow	556.0M	376.0M	463.0M	543.0M	478.0M
Financing Cash Flow	-472.0M	-273.0M	-373.0M	-231.0M	-306.0M
Net Change In Cash	-262.0M	311.0M	378.0M	68.9M	156.0M
Ending Cash Balance	1.2B	1.5B	1.2B	801.0M	732.0M
Capex	115.0M	21.2M	27.0M	76.9M	71.8M